INDICE DE ARTICULOS – Sociedad Chilena de Mastología

Hong Pan, MD, PhD; Hui Wang, MS; Mengjia Qian, MS; Xinrui Mao, MS; Guojian Shi, MS; Ge Ma, MD; Muxin Yu, MD; Hui Xie, MD; Lijun Ling, MD, PhD; Qiang Ding, MD, PhD; Kai Zhang, MS; Shui Wang, MD, PhD; Wenbin Zhou, MD, PhD.

ABRIL 2021

“Breast Cancer Risk Genes, Association Analysis in more than 113,000 women”

Breast Cancer Association Consortium

MARZO 2021

“Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement”

Benjamin D. Smith, MD1; Matthew P. Goetz, MD2,3; and Judy C. Boughey, MD4

FEBRERO 2021

“Reirradiation for Locoregional Recurrent Breast Cancer”

Sayeh Fattahi, BS,a Safia K. Ahmed, MD,b Sean S. Park, MD, PhD,b Ivy A. Petersen, MD,b Dean A. Shumway, MD,a Bradley J. Stish, MD,b Elizabeth S. Yan, MD,b Nicholas B. Remmes, PhD,b Robert W. Mutter, MD,b and Kimberly S. Corbin, MDb*, Advances in Radiation Oncology (2021) 6, 100640

ENERO 2021

“De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or Not to Boost? ”

Joseph Abi Jaoude, MD,* Majd Kayali, MD,* Evandro de Azambuja, MD, PhD,y Maha Makki, MS,z Hani Tamim, PhD,z Arafat Tfayli, MD,x Nagi El Saghir, MD,x Fady Geara, MD, PhD,* Martine Piccart, MD, PhD,y Philip Poortmans, MD, PhD,k and Youssef H. Zeidan, MD, PhD*

DICIEMBRE 2020

“The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer”

Mauricio Rivas1, Francisco Acevedo1, Francisco Dominguez2, Hector Galindo1, Mauricio Camus2, David Oddo3, Alejandra Villarroel3, Dravna Razmilic4, Jose Peña1, Matias Muñoz-Medel1, Maria Elena Navarro4, Alejandra Perez-Sepulveda1, Lidia Medina5, Tomas Merino1, Juan Briones1, Alexis Kalergis6, Cesar Sanchez1

NOVIEMBRE 2020

“Effect of mammographic screening from age 40 years on breast cáncer mortality (UK age trial): final result of a randomised, controlled trial.”

Stephen W Duffy, Daniel Vulkan, Howards Cuckle, Dharmishta Parma, Shama Sheikh, Robert A Smith, Andrew Evans, Oleg Blyuss, Louise Johns, Ian O Ellis, Jonathan Myles, Peter D Sasieni, Sue M Moss.

OCTUBRE 2020

“Irradiación parcial acelerada de mama comparada con irradiación completa de la mama para cáncer de mama temprano: resultados a largo plazo del estudio randomizado fase III APBI-IMRT-Florence.”

Icro Meattini, et all.

SEPTIEMBRE 2020

“Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium”

Jill R. Dietz, Meena S. Moran, Steven J. Isakof, Scott H. Kurtzman, Shawna C. Willey, Harold J. Burstein, Richard J. Bleicher, Janice A. Lyons, Terry Sarantou, Paul L. Baron, Randy E. Stevens, Susan K. Boolbol, Benjamin O. Anderson, Lawrence N. Shulman, William J. Gradishar, Debra L. Monticciolo, Donna M. Plecha, Heidi Nelson, Katharine A. Yao.

AGOSTO 2020

Five-Year Results Of The Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial

Sophie Bosma, Femke Leij, Sandra Vreedwijk, Michiel de Maaker, Jelle Wesseling, Marc Van de Vijver, Astrid Scholten, Sofía Rivera, Celine Bourgier, Guillaume Auzac, Theodoros Foukakis, Tobias Lekberg, Desiree Bongard, Claudette Loo, Emiel Rutgers, Harry Bartelink, Paula Elkhuizen. Int J Radiation Oncol Biol Phys, January 2020.

JULIO 2020

Resultados de Calidad de vida en mujeres sometidas a Reconstrucción Mamaria Autóloga versus Aloplástica luego de Mastectomía: Revisión Sistemática y Metanálisis

Yassir Eltahir, Irene Krabbe-Timmerman, Nadia Sadok, Paul Werker, Geertruida de Bock. Plastic and Reconstructive Surgery. May 2020.

JUNIO 2020

Pertuzumab, Trastuzumab and Docetaxel for Her2-Positive Metastatic Breast Cancer (Cleopatra): End-Of-Study Results From A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Study

Sandra M. Swain et al. Lancet Oncol 2020 21(4):519-530

MAYO 2020

Pembrolizumab for Early Triple-Negative Breast Cancer

P. Schmid, J. Cortes, L. Pusztai, H. McArthur, S. Kümmel, J. Bergh, C. Denkert, Y.H. Park, R. Hui, N. Harbeck, M. Takahashi, T. Foukakis, P.A. Fasching, F. Cardoso, M. Untch, L. Jia, V. Karantza, J. Zhao, G. Aktan, R. Dent, and J. O’Shaughnessy, for the KEYNOTE-522 Investigators.

ABRIL 2020

Radioterapia hipofraccionada de mama durante 1 semana versus 3 semanas (fast-forward): eficacia a 5 años y los efectos adversos de la radioterapia en los tejidos. Resultado de un ensayo multicéntrico, de no inferioridad, aleatorizado, fase 3

Dra. Bárbara Carreño Manríquez, Residente de Cirugía Hospital Clínico Universidad de Chile; Dra. Paula Escobar Oliva, UPM. Hospital Santiago Oriente.

MARZO 2020

Recomendaciones para la priorización de tratamiento de cáncer de mama durante Pandemia COVID19

Recopilación de artículos y públicaciones

FEBRERO 2020

Excelente Control Locorregional en Cáncer de Mama Inflamatorio con Radioterapia Personalizada

Shane R. Stecklein, MD et al, MDACC. Practical Radiation Oncology (2019) 9, 402-409; \\doi.org/10.1016/j.prro.2019.05.011

ENERO 2020

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

R.K. Murthy et al.

DICIEMBRE 2019

Resonancia magnética complementaria para mujeres con tejido mamario extremadamente denso

M.F. Bakker, S.V. de Lange, R.M. Pijnappel, R.M. Mann, P.H.M. Peeters, E.M. Monninkhof, M.J. Emaus, C.E. Loo, R.H.C. Bisschops, M.B.I. Lobbes, M.D.F. de Jong, K.M. Duvivier, J. Veltman, N. Karssemeijer, H.J. de Koning, P.J. van Diest, W.P.T.M. Mali, M.A.A.J. van den Bosch, W.B. Veldhuis, and C.H. van Gils, for the DENSE Trial Study Group*.

NOVIEMBRE 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

J.A. Sparano, NEJM 2019.

OCTUBRE 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

S.-A. Im, Y.-S. Lu, A. Bardia, N. Harbeck, M. Colleoni, F. Franke, L. Chow, J. Sohn, K.-S. Lee, S. Campos-Gomez, R. Villanueva-Vazquez, K.-H. Jung, A. Chakravartty, G. Hughes, I. Gounaris, K. Rodriguez-Lorenc, T. Taran, S. Hurvitz, and D. Tripathy

SEPTIEMBRE 2019

Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer

Christina Adaniel, MD; Francisca Salinas, RN; Juan Manuel Donaire, MD; Maria Eugenia Bravo, MD; Octavio Peralta, MD; Hernando Paredes, MD; Nuvia Aliaga, MD; Antonio Sola, MD; Paulina Neira, MD; Carolina Behnke, MD; Tulio Rodriguez, MD; Soledad Torres, MD; Francisco Lopez, MD; and Claudia Hurtado, PhD .

AGOSTO 2019

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37.298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). The Lancet, Volume 393, Issue 10179, 1440 - 1452.

JULIO 2019

Resultados a corto plazo de mastectomía con reconstrucción inmediata con implante definitivo, con y sin malla (iBRA): estudio multicéntrico, prospectivo de cohorte.

RiShelley Potter, Elizabeth J Conroy, Ramsey I Cutress, Paula R Williamson, Lisa Whisker, Steven Thrush, Joanna Skillman, Nicola L P Barnes, Senthurun Mylvaganam, Elisabeth Teasdale, Abhilash Jain, Matthew D Gardiner, Jane M Blazeby, Chris Holcombe, on behalf of the iBRA Steering Group* and the Breast Reconstruction Research Collaborative

JUNIO 2019

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

Rita S. Mehta, M.D., William E. Barlow, Ph.D., Kathy S. Albain, M.D., Ted A. Vandenberg, M.D.

MAYO 2019

FDG/PET-CT Based Lymph Node Atlas in Breast Cancer Patients.

Kai Joachim Borm, MD,* Julia Voppichler,*,y Mathias Du ̈sberg,* Markus Oechsner, PhD,* Tibor Vag, MD,z Wolfgang Weber, MD,x Stephanie Elisabeth Combs, MD,*,k, and Marciana Nona Duma, MD*

ABRIL 2019

Irradiación profiláctica sobre la mama contralateral en pacientes con mutación BRCA tratadas por cáncer de mama precoz.

E. Evron, A.M. Ben-David, H. Goldberg, G. Fried, B. Kaufman,
R. Catane, M.R. Pfeffer, D.B. Geffen, P. Chernobelsky, T. Karni,
R. Abdah-Bortnyak, O. Rosengarten, D. Matceyevsky, M. Inbar, A. Kuten and B.W. Corn.

MARZO 2019

Linfoma anaplásico de células grandes asociado a implantes de mama.

Dr. Juan Manuel Donaire Acevedo

FEBRERO 2019

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects

Valentina Ovalle, Eric A. Strom * ID, Simona Shaitelman, Karen Hoffman, Richard Amos, George Perkins, Welela Tereffe, Benjamin D. Smith, Michael Stauder and Wendy Woodward

ENERO 2019

Neoadjuvant chemotheray and timming of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla

Zhao Bi – Jingjing Liu – Peng Chen – Tong Zhao
Chunjian Wang – Zhaopeng Zhang – Xiao Sun – Pengfei Qiu
– Xianrang Song – Yongsheng Wang

DICIEMBRE 2018

Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study

Tomas Merino Lara
Oncología - Radioterapia
Universidad Católica

NOVIEMBRE 2018

Intensive Surveillance with Bi-Anual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers

Dra. M. Catalina Vial Alliende
Red Salud UC-Christus
Centro Metropolitano de Imágenes Mamarias (CMIM)

OCTUBRE 2018

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Dr. Felipe Ubilla
Fellow Mastología
HCSBA - UCHILE

SEPTIEMBRE 2018

Cosmesis after early stage breast cancer treatment with surgery and radiation therapy: experience of patients treated in a Chilean radiotherapy centre

Dra. Lorena Vargas
Radioterapia Oncológica
Clínica IRAM

AGOSTO 2018

Long-term risks of secondary cancer for various whole and partial breast irradiation techniques

Tomas Merino L
Radioterapia Oncológica
Radio Oncólogo

JULIO 2018

Tratamiento basado en Trastuzumab para el Cáncer de Mama que Sobreexpresan el Gen HER2

César Sánchez
Oncólogo Médico PUC
Lidia Medina
Enfermera Universitaria. Centro del Cáncer. PUC

JUNIO 2018

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Dra. Bettina Müller
Director GOCCHI
Oncóloga Médico
Profesor Adjunto Asociado
Jefe Centro de Responsabilidad Oncología Médica
Instituto Nacional Del Cáncer

MAYO 2018

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Dra. Lorena Vargas
Radioterapia Oncológica
Clínica IRAM

ABRIL 2018

Resultados del Tratamiento del Cáncer de Mama, Programa Nacional de Cáncer del Adulto.

Dr. César Del Castillo
Jefe de Oncología
Hospital Clínico San Borja Arriarán

MARZO 2018

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Dra. Valentina Ovalle
Clínica IRAM

FEBRERO 2018

AJCC 8th Edition Cancer Staging Manual.

Rodrigo Bertin Langbein
Oncólogo Médico - Medicina Interna
Hospital Clínico San Borja Arriarán